Xpert MTB/RIF for diagnosis of tuberculous cervical lymphadenitis in HIV‐infected patients
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Objectives/Hypothesis: The World Health Organization endorsed the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis (TB), but there is limited information about the utility of this assay for the diagnosis of TB lymphadenitis. Therefore, the objective of this study was to assess the diagnostic accuracy of Xpert MTB/RIF assay in HIV‐infected patients with palpable cervical lymph nodes. Study Design: Prospective, diagnostic test study. Methods: Consecutive patients with cervical lymphadenopathy were prospectively enrolled between January 2011 and March 2013. Lymph node specimens were obtained through fine‐needle aspiration or excisional biopsy. Mycobacterial culture was considered as the gold standard. Results: Mycobacterium TB was cultured from 15 of 68 specimens (22.05%), and 53 specimens had negative cultures (77.94%). The sensitivity of Xpert MTB/RIF was 100% (95% CI, 74.65%–100%), and the specificity was 100% (95% CI, 91.58%–100%). Smear microscopy had a lower diagnostic performance. Conclusion: Although based on a limited sample size, our study indicates that Xpert MTB/RIF is a useful method for the diagnosis of cervical TB lymphadenitis in HIV‐infected patients, regardless of the bacillary load in smear‐positive samples or the CD4 T cell count. The sensitivity, specificity, positive predictive value, and negative predictive value were similar to gold‐standard culture. Level of Evidence: N/A. Laryngoscope, 124:1382–1385, 2014
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Nevertheless, only 4 studies exclusively focused on the diagnosis of TL, all of them performed in high incidence areas for tuberculosis, showing a sensitivity of 93% to 100%.22–25”
From Epidemiology and Diagnosis of Tuberculous Lymphadenitis in a Tuberculosis Low-Burden Country (2015) · cites this paper as [24]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rapid Molecular Detection of Tuberculosis and Rifampin Resistance
Boehme, C. C., Nabeta, P., Hillemann, D., Nicol, M. P., Shenai, S., Krapp, F., Allen, J., Tahirli, R., Blakemore, R., Rustomjee, R., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907847 · Cited by 2,309
Helb, D., Jones, M., Story, E., Boehme, C., Wallace, E., Ho, K., Kop, J., Owens, M. R., Rodgers, R., Banada, P., et al. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.01463-09 · Cited by 914 · cited 1×
“The Xpert assay was performed as described previously.(13) A 2:1 volume of sample reagent buffer was added to very small”
MethodXpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults
Steingart, K. R., Sohn, H., Schiller, I., Kloda, L. A., Boehme, C. C., Pai, M., & Dendukuri, N. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009593.pub2 · Cited by 253
Ligthelm, L. J., Nicol, M. P., Hoek, K. G. P., Jacobson, R., van Helden, P. D., Marais, B. J., Warren, R. M., & Wright, C. A. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.01310-11 · Cited by 123 · cited 1×
“, who previously reported the utility of Xpert for the diagnosis of TB lymphadenitis from FNA biopsy specimens.(15) The elevated rate of cervical TB lymphadenitis in EPTB cases(6) and the high performance of Xpert in lymph node tissue observed here become particularly relevant in resourcelimited settings, where HIV-in…”
BackgroundVan Rie, A., Page-Shipp, L., Mellet, K., Scott, L., Mkhwnazi, M., Jong, E., Omar, T., Beylis, N., Stevens, W., Sanne, I., et al. (2013) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-013-1890-0 · Cited by 24
Research works printed but not linked: 10
- Centers for Disease Control and Prevention, 2011, Reported tuberculosis in the United States, 2010
- SandgrenA HolloV van derWerfMJ.Extrapulmonary tuberculosis in the European Union and European Economic Area 2002 to 2011. Euro Surveill 2013. Available at:http://www.eurosurveillance.org/ViewArticle. aspx?ArticleId=20431. Accessed April 20 2013. · DOI · Paper page
- 10.1093/cid/cis303 · DOI · Paper page
- Golden MP, 2005, Extrapulmonary tuberculosis: an overview, Am Fam Phys, 72, 1761
- 10.1097/01.aids.0000161769.06158.8a · DOI · Paper page
- Kent PT, 1985, Public health mycobacteriology. A guide for a level III laboratory
- Centers for Disease Control and Prevention, 2000, Update: nucleic acid amplification tests for tuberculosis, MMWR, 49, 593
- 10.1016/j.jinf.2012.02.012 · DOI · Paper page
- Poprawski D, 2000, Clinical presentations and outcomes of TB among HIV‐positive patients, Southeast Asian J Trop Med Public Health, 31, 140
- 10.1371/journal.pmed.1001120 · DOI · Paper page
Cited by
Xpert ® MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance
Kohli, M., Schiller, I., Dendukuri, N., Dheda, K., Denkinger, C. M., Schumacher, S. G., & Steingart, K. R. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012768.pub2 · Cited by 245
Kohli, M., Schiller, I., Dendukuri, N., Yao, M., Dheda, K., Denkinger, C. M., Schumacher, S. G., & Steingart, K. R. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012768.pub3 · Cited by 215
Epidemiology and Diagnosis of Tuberculous Lymphadenitis in a Tuberculosis Low-Burden Country
Salvador, F., Los-Arcos, I., Sánchez-Montalvá, A., Tórtola, T., Curran, A., Villar, A., Saborit, N., Castellví, J., & Molina, I. (2015) · Medicine · doi:10.1097/md.0000000000000509 · Cited by 43
Metadata
- Authors
- Ablanedo‐Terrazas, Y., Alvarado‐de la Barrera, C., Hernández‐Juan, R., Ruiz‐Cruz, M., & Reyes‐Terán, G.
- Affiliations
- Centro de Investigación en Enfermedades Infecciosas Instituto Nacional de Enfermedades Respiratorias Mexico City Mexico
- Venue
- The Laryngoscope
- Publisher
- Wiley
- Published
- 2013-12-09
- Volume
- 124
- Issue
- 6
- Pages
- 1382-1385
- ISSN
- 0023-852X
- 1531-4995
- Cited by
- 13
- References
- 5
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Xpert MTB/RIF for diagnosis of tuberculous cervical lymphadenitis in HIV‐infected patients. https://app.cochat.ai/papers/10.1002/lary.24478
- The paper
- Ablanedo‐Terrazas, Y., Alvarado‐de la Barrera, C., Hernández‐Juan, R., Ruiz‐Cruz, M., & Reyes‐Terán, G. (2014). Xpert MTB/RIF for diagnosis of tuberculous cervical lymphadenitis in HIV‐infected patients. The Laryngoscope. https://doi.org/10.1002/lary.24478
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.